cro.directory
← Compare landing

GemPharmatech vs PharmaLegacy Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/gempharmatech/pharmalegacy

CategoryGemPharmatechPharmaLegacy Laboratories
Listed sitecrocro
SummaryGemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.Preclinical CRO with over 1,500 validated in vivo efficacy models spanning 100+ indications in oncology, immunology, inflammation, and bone disease. AAALAC-accredited vivarium with capacity for 30,000 rodents and 350 non-human primates supports IND filings to FDA and CFDA.
Services
  • Specialized & Large-Animal Models
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Target Identification & Validation
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Safety Pharmacology
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • US FDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Oncology
  • Metabolic
  • Cardiovascular
  • Immunology
  • Neurology
  • Infectious Disease
  • Rare Disease
  • Oncology
  • Immunology
  • Rare Disease
Locations
  • Headquarters, Jiangsu, China
  • Headquarters
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.